Israel Englander Cidara Therapeutics, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$1.01 - $1.42 $120,381 - $169,249
119,190 New
119,190 $134,000
Q4 2022

Feb 14, 2023
BUY
$0.48 - $13.08 $290,976 - $7.93 Million
606,201 Added 724.12%
689,917 $522,000
Q3 2022

Nov 14, 2022
BUY
$0.45 - $13.0 $14,427 - $416,806
32,062 Added 62.07%
83,716 $53,000
Q2 2022

Aug 15, 2022
BUY
$0.43 - $0.91 $2,795 - $5,915
6,501 Added 14.4%
51,654 $25,000
Q1 2022

May 16, 2022
SELL
$0.67 - $1.39 $27,221 - $56,474
-40,629 Reduced 47.36%
45,153 $38,000
Q4 2021

Feb 14, 2022
SELL
$1.18 - $2.18 $274,193 - $506,560
-232,367 Reduced 73.04%
85,782 $109,000
Q3 2021

Nov 15, 2021
SELL
$1.48 - $2.35 $388,713 - $617,213
-262,644 Reduced 45.22%
318,149 $713,000
Q2 2021

Aug 16, 2021
BUY
$1.87 - $2.7 $966,833 - $1.4 Million
517,023 Added 810.76%
580,793 $1.17 Million
Q1 2021

May 17, 2021
SELL
$2.06 - $3.01 $279,303 - $408,107
-135,584 Reduced 68.01%
63,770 $170,000
Q4 2020

Feb 16, 2021
BUY
$1.99 - $3.25 $396,714 - $647,900
199,354 New
199,354 $399,000
Q2 2020

Aug 14, 2020
SELL
$2.39 - $4.0 $128,280 - $214,696
-53,674 Closed
0 $0
Q1 2020

May 14, 2020
SELL
$1.74 - $4.26 $71,362 - $174,715
-41,013 Reduced 43.31%
53,674 $133,000
Q4 2019

Feb 14, 2020
BUY
$1.77 - $3.84 $167,595 - $363,598
94,687 New
94,687 $364,000
Q3 2019

Nov 14, 2019
SELL
$1.25 - $2.35 $236,428 - $444,486
-189,143 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$1.49 - $2.94 $266,024 - $524,907
178,540 Added 1683.86%
189,143 $318,000
Q2 2019

Aug 14, 2019
SELL
$1.49 - $2.94 $323,200 - $637,724
-216,913 Reduced 95.34%
10,603 $140,000
Q1 2019

May 14, 2019
BUY
$2.35 - $3.27 $39,242 - $54,605
16,699 Added 7.92%
227,516 $603,000
Q4 2018

Feb 14, 2019
SELL
$2.1 - $4.5 $475,095 - $1.02 Million
-226,236 Reduced 51.76%
210,817 $495,000
Q3 2018

Nov 14, 2018
SELL
$3.7 - $5.25 $1.06 Million - $1.5 Million
-285,773 Reduced 39.54%
437,053 $1.92 Million
Q2 2018

Aug 14, 2018
BUY
$3.75 - $6.05 $499,361 - $805,636
133,163 Added 22.58%
722,826 $3.76 Million
Q1 2018

May 15, 2018
SELL
$4.0 - $8.15 $15,600 - $31,785
-3,900 Reduced 0.66%
589,663 $2.36 Million
Q4 2017

Feb 14, 2018
SELL
$6.35 - $8.75 $70,021 - $96,486
-11,027 Reduced 1.82%
593,563 $4.04 Million
Q3 2017

Nov 14, 2017
BUY
$5.75 - $8.1 $3.48 Million - $4.9 Million
604,590
604,590 $4.9 Million

About Cidara Therapeutics, Inc.

CDTX Quotes by TradingView
  • Ticker CDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,075,696
  • Market Cap $1.43B
  • Description
  • Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifu...
More about CDTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email